COVID-19 vaccine trials for children are ongoing. How do they differ from adults?
2021-07-20 from globalnews.ca
Eight months since the first COVID-19 vaccines began rolling out in Canada, safety and efficacy of the shots among babies and younger children are still being investigated.
In Canada, so far only Pfizer-BioNTech’s COVID-19 vaccine has been authorized for use in children aged 12 years and above. Moderna submitted its application for approval to Health Canada in June.
But kids under 12, including toddlers, are waiting for their turn as a number of clinical trials are under way.
Vaccinating this group will enable a safer reopening of schools, a return to normalcy as well as control the disease’s spread to more vulnerable adults, experts say.
“Kids are largely asymptomatic and so they will be transmitting the virus and they’ll remain reservoirs of the virus,” said Fatima Kakkar, a pediatric infectious diseases physician at CHU Sainte-Justine in Montreal.
Read more here